Yahoo Web Search

  1. Ads

    related to: cells, immune system

Search results

    • Small Business - The Brewton Standard | The Brewton Standard

      The Brewton Standard· 7 hours ago

      Sapience Therapeutics Presents Positive Clinical and Biomarker Data from ST101 Phase 2 Study in GBM at ASCO 2024 in Oral Presentation PR Newswire TARRYTOWN, N.Y., June 1, 2024 -Data demonstrates durable responses across 3 cohorts of patients with

    • Small Business - Cordele Dispatch | Cordele Dispatch

      Cordele Dispatch· 29 minutes ago

      Innovent Presents Phase 1 Clinical Data of First-in-class PD-1/IL-2α Bispecific Antibody Fusion Protein (IBI363) in Melanoma, Colorectal Cancer and other Solid Tumors at the 2024 ASCO Annual Meeting PR Newswire SAN FRANCISCO, U.S. and SUZHOU, China